Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
PublicSource on MSN
Cuts in funds for HIV services threaten medication access, outreach
The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising ...
He is regularly dubbed the world's best ever diver, but Olympic gold medallist Greg Louganis still questions whether he missed out on lucrative sponsorship deals and top TV jobs because he was gay and ...
StockStory.org on MSN
Gilead Sciences’s Q3 Earnings Call: Our Top 5 Analyst Questions
Gilead Sciences’ third quarter was marked by strong sales growth in its HIV and liver disease portfolios, but the market ...
Franklin County commissioners Rocky Mullen and Clint Didier opposed the increases, while Benton County commissioners Michael ...
Stockhead on MSN
Biocurious: ‘My finest hour and my biggest regret’ – biotech veterans reflect on two decades in the game
At a recent lunch in Melbourne, two dozen luminaries exchanged war stories about their two decades-plus involvement in the ...
Gita Kamath, Deputy Ambassador of Australia to Indonesia, stated that 29 Australian companies are exploring commercial ...
Microsoft announced that CloudFit Software has been named the winner of the 2025 Microsoft Global Defense and Intelligence Partner of the Year Award. The company was honored among a global field of ...
Monitor on MSN
Lira City: Powerful figures clash in high-stakes contest
Ms Amongi says UPC flag bearers will sweep all the parliamentary seats in this principal trade centre of Lango sub-region, ...
John Laws, also known as "Golden Tonsils", spent a mammoth 71 years on air at stations such as Sydney's 2UE and 2SM, before ...
Silicon Valley startups are pushing the boundaries of reproductive genetics, hoping to prevent diseases as well as improve chances for a high IQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results